10:35 AM EST - Microbix Biosystems Inc. : Will present performance results of its Quality Assessment Products supporting molecular-diagnostic tests for the Omicron variant of the SARS-CoV-2 virus at the 2022 Clinical Virology Symposium of the American Society for Microbiology taking place in West Palm Beach, Florida from May 1-4. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.52.
